Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

RICHARD CHANNICK

Allopathic & Osteopathic Physicians Internal Medicine Critical Care Medicine

NPI
1144255886
CMS profile
233605
Location
BOSTON, MA

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2023 · Entire year

$86,680.31

151 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2023 · entire year · sorted by reported total

By paying entity

PY2023 · entire year · sorted by reported total

Paying entityAmountRecords
Actelion Pharmaceuticals US, Inc. $46,482.51 69
Merck Sharp & Dohme LLC $18,637.90 26
Penumbra, Inc. $14,742.33 18
Bayer Healthcare Pharmaceuticals Inc. $4,211.04 16
United Therapeutics Corporation $2,092.42 17
Inari Medical, Inc. $360.44 3
Janssen Pharmaceuticals, Inc $123.06 1
Sandoz Inc. $30.61 1

Page 2 of 4; records 51–100 of 151 matching records. This page contains 50 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

RICHARD CHANNICK

NPI 1144255886 · CMS profile ID 233605

Allopathic & Osteopathic Physicians / Internal Medicine / Critical Care Medicine

BOSTON, MA

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 2 of 4; records 51–100 of 151 matching records. This page contains 50 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1144255886?year=2023&recipient=provider&page=2#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
RICHARD CHANNICK, NPI 1144255886, CMS profile ID 233605. General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 4; records 51–100 of 151 matching records. This page contains 50 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1144255886?year=2023&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9.
APA 7
IndustryPayments. (2026). RICHARD CHANNICK, NPI 1144255886, CMS profile ID 233605. General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 4; records 51–100 of 151 matching records. This page contains 50 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1144255886?year=2023&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9.
Bluebook
RICHARD CHANNICK, NPI 1144255886, CMS profile ID 233605, IndustryPayments, General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 2 of 4; records 51–100 of 151 matching records. This page contains 50 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9. https://industrypayments.org/provider/npi-1144255886?year=2023&recipient=provider&page=2#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2023

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2023 · Physicians and non-physician practitioners · CMS publication 2026-06-30

151 matching records · $86,680.31 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 151 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 51–100 of 151.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
Actelion Pharmaceuticals US, Inc. $620.0007/05/2023 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 988491826 CMS
Actelion Pharmaceuticals US, Inc. $29.5907/05/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 988491937 CMS
Penumbra, Inc. $5,125.0007/03/2023 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 993682361 CMS
Actelion Pharmaceuticals US, Inc. $43.2406/30/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 988492497 CMS
Actelion Pharmaceuticals US, Inc. $4,340.0006/28/2023 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 988492271 CMS
Actelion Pharmaceuticals US, Inc. $4,340.0006/28/2023 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 988492289 CMS
United Therapeutics Corporation $34.6906/28/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1050963839 CMS
Merck Sharp & Dohme LLC $465.0006/26/2023 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1048282637 CMS
Bayer Healthcare Pharmaceuticals Inc. $33.3606/21/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1000431285 CMS
Actelion Pharmaceuticals US, Inc. $31.0406/20/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 988492367 CMS
Penumbra, Inc. $421.4706/17/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1025498839 CMS
Actelion Pharmaceuticals US, Inc. $125.0006/14/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 988492260 CMS
Actelion Pharmaceuticals US, Inc. $16.5106/14/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 988492279 CMS
Actelion Pharmaceuticals US, Inc. $821.1006/14/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 988492299 CMS
Actelion Pharmaceuticals US, Inc. $1,345.6006/14/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 988492309 CMS
Actelion Pharmaceuticals US, Inc. $236.2606/14/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 988492319 CMS
Actelion Pharmaceuticals US, Inc. $3.4806/13/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 988492357 CMS
Merck Sharp & Dohme LLC $597.1406/12/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1048282641 CMS
Merck Sharp & Dohme LLC $3,255.0006/12/2023 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1048283027 CMS
Penumbra, Inc. $111.8106/02/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1025498833 CMS
Penumbra, Inc. $92.9006/02/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1025498835 CMS
Penumbra, Inc. $117.5706/02/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1025498837 CMS
Penumbra, Inc. $711.8006/01/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 987686941 CMS
Penumbra, Inc. $255.9906/01/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 987686957 CMS
Penumbra, Inc. $119.0006/01/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 987686959 CMS
Actelion Pharmaceuticals US, Inc. $27.5705/31/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 988492339 CMS
Actelion Pharmaceuticals US, Inc. $2.3705/31/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 988492347 CMS
Penumbra, Inc. $119.0005/30/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1025498829 CMS
Penumbra, Inc. $255.9905/30/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1025498831 CMS
Actelion Pharmaceuticals US, Inc. $550.0005/25/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 988492237 CMS
Actelion Pharmaceuticals US, Inc. $6,510.0005/25/2023 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 988492249 CMS
Merck Sharp & Dohme LLC $59.1505/22/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1048282761 CMS
Actelion Pharmaceuticals US, Inc. $144.6705/21/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 988492077 CMS
Actelion Pharmaceuticals US, Inc. $144.6705/21/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 988492087 CMS
Actelion Pharmaceuticals US, Inc. $144.6705/21/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 988492097 CMS
Actelion Pharmaceuticals US, Inc. $144.6705/21/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 988492107 CMS
Actelion Pharmaceuticals US, Inc. $141.2305/20/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 988492507 CMS
Merck Sharp & Dohme LLC $42.2305/20/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1048282763 CMS
Actelion Pharmaceuticals US, Inc. $1,240.0005/17/2023 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 988492209 CMS
Actelion Pharmaceuticals US, Inc. $3,720.0005/17/2023 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 988492229 CMS
Actelion Pharmaceuticals US, Inc. $25.8005/17/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 988492477 CMS
Actelion Pharmaceuticals US, Inc. $2.4305/17/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 988492487 CMS
United Therapeutics Corporation $1,443.7505/17/2023 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1050971143 CMS
Actelion Pharmaceuticals US, Inc. $146.2505/11/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 988492219 CMS
United Therapeutics Corporation $117.6105/11/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1050968021 CMS
Bayer Healthcare Pharmaceuticals Inc. $34.8605/10/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1000431355 CMS
Actelion Pharmaceuticals US, Inc. $4,340.0005/08/2023 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 988492127 CMS
Actelion Pharmaceuticals US, Inc. $3,720.0005/08/2023 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 988492179 CMS
United Therapeutics Corporation $18.0005/06/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1050951285 CMS
United Therapeutics Corporation $18.0005/06/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1050951287 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $125,756.78 111
PY2020 $61,650.96 55
PY2021 $35,407.57 44
PY2022 $100,531.19 108
PY2023 $86,680.31 151
PY2024 $101,316.89 156
PY2025 $126,333.64 191

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2023 Recipient $7,012.79 4
PY2019 Principal investigator $5,750.00 2

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2023

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

4 records in PY2023

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Recipient United Therapeutics Corporation $60.00 06/06/2023 Covered Recipient Physician A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO EVALUATE THE EFFICACY AND SAFETY OF RALINEPAG WHEN ADDED TO PAH STANDARD OF CARE OR PAH-SPECIFIC BACKGROUND ORAL THERAPY IN SUBJECTS WITH WHO GROUP I PULMONARY HYPERTENSION No dispute reported 06/30/2026 1051198609
Recipient United Therapeutics Corporation $4,060.00 06/06/2023 Covered Recipient Physician A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO EVALUATE THE EFFICACY AND SAFETY OF RALINEPAG WHEN ADDED TO PAH STANDARD OF CARE OR PAH-SPECIFIC BACKGROUND ORAL THERAPY IN SUBJECTS WITH WHO GROUP I PULMONARY HYPERTENSION No dispute reported 06/30/2026 1051198617
Recipient United Therapeutics Corporation $2,320.00 06/06/2023 Covered Recipient Physician A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO EVALUATE THE EFFICACY AND SAFETY OF RALINEPAG WHEN ADDED TO PAH STANDARD OF CARE OR PAH-SPECIFIC BACKGROUND ORAL THERAPY IN SUBJECTS WITH WHO GROUP I PULMONARY HYPERTENSION No dispute reported 06/30/2026 1051198619
Recipient United Therapeutics Corporation $572.79 06/06/2023 Covered Recipient Physician A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO EVALUATE THE EFFICACY AND SAFETY OF RALINEPAG WHEN ADDED TO PAH STANDARD OF CARE OR PAH-SPECIFIC BACKGROUND ORAL THERAPY IN SUBJECTS WITH WHO GROUP I PULMONARY HYPERTENSION No dispute reported 06/30/2026 1051198621